Valion Bio (TIVC) Other Non-Current Assets (2021 - 2025)
Valion Bio has reported Other Non-Current Assets over the past 5 years, most recently at $136000.0 for Q4 2025.
- For Q4 2025, Other Non-Current Assets changed N/A year-over-year to $136000.0; the TTM value through Dec 2025 reached $136000.0, changed N/A, while the annual FY2025 figure was $136000.0, N/A changed from the prior year.
- Other Non-Current Assets for Q4 2025 was $136000.0 at Valion Bio, up from $23000.0 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $136000.0 in Q4 2025 and troughed at $2000.0 in Q1 2025.
- A 5-year average of $36928.6 and a median of $34000.0 in 2022 define the central range for Other Non-Current Assets.
- Biggest five-year swings in Other Non-Current Assets: increased 3.03% in 2023 and later crashed 94.12% in 2025.
- Year by year, Other Non-Current Assets stood at $49000.0 in 2021, then tumbled by 30.61% to $34000.0 in 2022, then changed by 0.0% to $34000.0 in 2023, then changed by 0.0% to $34000.0 in 2024, then skyrocketed by 300.0% to $136000.0 in 2025.
- Business Quant data shows Other Non-Current Assets for TIVC at $136000.0 in Q4 2025, $23000.0 in Q3 2025, and $2000.0 in Q2 2025.